期刊文献+

分时段系统超声检查对筛查胎儿畸形的临床意义 被引量:3

Clinical significance of the stage system ultrasonography for screening the fetal deformity
下载PDF
导出
摘要 目的探讨分时段系统超声检查对筛查胎儿畸形的临床价值。方法根据胎儿生长发育特点,对12380例孕11~40周的胎儿进行分时段系统超声筛查,对畸形胎儿作出诊断。结果12380例胎儿中,经产后证实胎儿畸形223例,产前超声筛查诊断胎儿畸形212例,检出率95.07%,漏诊11例,漏诊率4.93%。结论分时段系统产前超声筛查,能较清晰地显示胎儿各时期的形态结构,是产前及时发现胎儿畸形,及时终止妊娠,确保出生质量的重要手段。 Objective To determine the clinical significance of the stage system ultrasonography(SSUS) for screening the fetal de- formity. Methods According to the prenatal growth and development characteristics of the fetus, 12,380 pregnant women with gestational age of 11-40 weeks underwent SSUS. Results Among 12,380 fetus whose mother underwent SSUS during different periods of the gestation, total 223 fetus were demonstrated to have various deformities after birth, of whom, 212 fetus with deformity were detected by prenatal SSUS. The detection rate of fetal deformity in the group was 95.07 % but 11 cases were leak-diagnosed, thus the leak-diagnostic rate was 4.93 %. Conclusion The prenatal SSUS can clearly visualize the fetal shape and strueture at different periods and therefore it is an important means for timely find the fetal deformity, timely terminate the pregnancy and precisely ensure the birth quality.
作者 文兰 罗模莉
出处 《实用医学影像杂志》 2009年第4期258-259,264,共3页 Journal of Practical Medical Imaging
关键词 分时段系统产前超声 胎儿畸形 出生质量 Stage system uhrasonography Fetal deformity Birth quality
  • 相关文献

参考文献6

二级参考文献14

  • 1佘志红,熊奕,王慧芳,吴瑛,林琪.规范化中孕期超声筛查胎儿畸形的临床价值[J].华中科技大学学报(医学版),2006,35(3):418-420. 被引量:18
  • 2Leschot NJ,Vejerslev LO. Proceedings of the EUCROMIC work-shop on prenatal diagnosis[J]. Eur J Hum Genet, 1997, 5(Suppl 1):1-90.
  • 3Szabo I, Csabay L, Toth Z, et al, Quality assurance in obstetric and gynecologic ultrasound, The Hungarian model[J]. Ann N Y Acad Sci,1998,847(1) :99-102.
  • 4AlUM practice guideline for the performance of an antepartum obstetric ultrasound examination [J]. J Ultrasound Med, 2003, 22(10):1116-1125.
  • 5Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities[J].Am J Obstet Gynecol, 2004,191(1):45-67.
  • 6Locatelli A, Piccoli MG, Vergani P, et al. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome[J].Am J Obstet Gynecol, 2000,182(1 Pt 1):192-197.
  • 7Zopi MA, Ibba RM, Floris M, et al. Nuchal translucency measure-ment at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening[J].Prenat Diagn, 2005,25(5):411-416.
  • 8Nicolaidees KH, Heath V, Cicero S. Increased fetal nuchal trans-lucency at 11-14 week[J]. Prenat Diagn, 2002,22(4):308-315.
  • 9Shaders RJ, Noble P, Sebire N assessment of risk of trizomy 21 translucency thickness at 10-14 1998,352(9125):343-346. et al. UK multicentre project on by maternal age and fetal nuchal weeks of gestation [J].Lancet,1998,352(9125):343-346.
  • 10Makrydimas G, Sotiriadis A, loannidis JP. Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis[J]. Am J Obstet Gycecol, 2003,189(5):1330-1335.

共引文献43

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部